Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
18.10
-0.03 (-0.17%)
At close: Apr 1, 2026, 4:00 PM EDT
18.25
+0.15 (0.83%)
After-hours: Apr 1, 2026, 5:49 PM EDT
Dyne Therapeutics Analyst Ratings
Total Analysts
14
Consensus Rating
Strong Buy
Price Target
$37.00
Upside
+104.42%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $38 | Strong Buy | Maintains | $38 | +109.94% | Mar 9, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $50 → $47 | Buy | Maintains | $50 → $47 | +159.67% | Mar 3, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $38 | Strong Buy | Maintains | $38 | +109.94% | Mar 3, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $50 | Strong Buy | Maintains | $60 → $50 | +176.24% | Mar 3, 2026 |
| JP Morgan | JP Morgan | Hold Maintains $17 → $16 | Hold | Maintains | $17 → $16 | -11.60% | Jan 20, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $38 → $36 | Buy | Maintains | $38 → $36 | +98.90% | Dec 15, 2025 |
| Stifel | Stifel | Strong Buy Maintains $36 → $39 | Strong Buy | Maintains | $36 → $39 | +115.47% | Dec 11, 2025 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $11 → $40 | Hold → Buy | Upgrades | $11 → $40 | +120.99% | Dec 10, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $46 → $50 | Buy | Maintains | $46 → $50 | +176.24% | Dec 9, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $38 | Strong Buy | Maintains | $38 | +109.94% | Dec 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $46 → $60 | Strong Buy | Maintains | $46 → $60 | +231.49% | Dec 8, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $18 → $17 | Hold | Maintains | $18 → $17 | -6.08% | Nov 14, 2025 |
| Oppenheimer | Oppenheimer | Hold Maintains $13 → $11 | Hold | Maintains | $13 → $11 | -39.23% | Nov 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $38 → $46 | Strong Buy | Maintains | $38 → $46 | +154.14% | Nov 6, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $23 → $30 | Buy | Maintains | $23 → $30 | +65.75% | Nov 6, 2025 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades $13 | Buy → Hold | Downgrades | $13 | -28.18% | Oct 10, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.